JPRN-UMIN000005559招募中1 期
Preoperative chemotherapy with gemcitabine and S-1, evaluation of safety and efficiency - Preoperative chemotherapy with gemcitabine and S-1, evaluation of safety and efficiency
Division of Hepato-Biliary Pancreatic Surgery , Tohoku University Hospital0 个研究点目标入组 20 人开始时间: 2011年5月9日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) with severe infection (2) with fever >38 degrees C (3) Serious complications (e.g. severe heart desease, plumonary fibrosis, interstitial pneumonia) (4) past history of plumonary fibrosis, interstitial pneumonia or renal failure with dialysis) (5) Simultaneous or metachronous (within 5 years) double cancers, with the exception of intramucosal tumor curable with local therapy (6) with brain metastasis (7) with pericardial fluid (8)Pregnant or lactating women or women of childbearing potential (restrict lactating within 8 weeks after last Panitmumab administration) (9)Patient with severe drug allergy (10)Psychosis or severe mental disorder (11)Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
已完成
1 期
eoadjuvant chemotherpy with gemcitabine and oral S-1for pancreatic cancerresectable pancreatic cancerJPRN-UMIN000011064Department of Gastroenterologic Surgery, Kanazawa University18
已完成
1 期
preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 studyresectable and borderline resectable pancreatic cancerJPRN-UMIN000020977fukushima medical university30
尚未招募
3 期
Perioperative Gemcitabine based chemotherapy vs surgery and adjuvant CAPECITABINE and chemo-radiation in operable GBCCTRI/2024/08/072162Tata Memorial Hospital
已完成
1 期
Phase I study of chemotherapy with gemcitabine, CDDP and S-1 for the patients with unresectable biliary tract cancerJPRN-UMIN000008415Jikei University School of Medicine24
进行中（未招募）
1 期
Study in Gallbladder or bile duct cancer comparing chemotherapy with gemcitabine plus cisplatin before and after radical liver resection with direct radical liver resection followed by chemotherapy or no chemotherapy (physician's decision) - A Phase III study of the German Gallbladder Cancer RegistryEUCTR2017-004444-38-ATKrankenhaus Nordwest gGmbH300